Page last updated: 2024-08-22

fluorescein-5-isothiocyanate and lovastatin

fluorescein-5-isothiocyanate has been researched along with lovastatin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adachi, H; Arai, H; Fukasawa, M; Hirota, K; Inoue, K; Mimura, K; Murakami-Murofushi, K; Tsujimoto, M1
Dimitroulakos, J; Minden, MD; Penn, LZ; Tan, MM; Wong, WW; Xia, Z1
Damrot, J; Epe, B; Fritz, G; Kaina, B; NĂ¼bel, T; Roos, WP1

Other Studies

3 other study(ies) available for fluorescein-5-isothiocyanate and lovastatin

ArticleYear
Chinese hamster ovary cells expressing a novel type of acetylated low density lipoprotein receptor. Isolation and characterization.
    The Journal of biological chemistry, 1995, Jan-27, Volume: 270, Issue:4

    Topics: Albumins; Animals; Binding, Competitive; Cell Adhesion Molecules; CHO Cells; Cricetinae; Dextran Sulfate; Dextrans; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gene Expression; Heparin; Humans; Kinetics; Lipoproteins, LDL; Liposomes; Lovastatin; Microscopy, Fluorescence; Poly I; Polysaccharides; Receptors, LDL; Receptors, Scavenger; Serum Albumin, Bovine; Simvastatin

1995
Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells.
    Leukemia, 2001, Volume: 15, Issue:9

    Topics: Acute Disease; Apoptosis; Benzamides; Deoxyuracil Nucleotides; Fluorescein-5-isothiocyanate; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukemia, Myeloid; Lovastatin; Methionine; Mevalonic Acid; Polyisoprenyl Phosphates; Protein Prenylation; Sesquiterpenes; Tumor Cells, Cultured

2001
Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide.
    British journal of pharmacology, 2006, Volume: 149, Issue:8

    Topics: Antibiotics, Antineoplastic; Antimutagenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Survival; DNA Damage; DNA Replication; Doxorubicin; Drug Resistance, Neoplasm; Endothelial Cells; Etoposide; Fibroblasts; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Topoisomerase II Inhibitors

2006